Published in Gene Therapy Weekly, February 14th, 2008
"One obstacle in implementation of adoptive immunotherapy has been insufficient sensitization and expansion of turnour-specific effector cells. In this study, we aim to improve adoptive immunotherapy by generating anti-tumour effector T cells from naive T lymphocytes. We...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.